San Antonio – CytoBioScience, a bioscience company that canceled plans to merge with a publicly traded business last year, may have new merger plans.
The San Antonio-based business raised a $1.53 million equity round of funding, according to a document filed with the SEC, which states that the funds are being raised in connection with an intended merger. The filing didn’t reveal any additional details and CytoBioScience hasn’t responded to requests for comment.
Founded in Germany, CytoBioScience moved to San Antonio in 2015. It sells a device, the CytoPatch, for screening the safety and efficacy of drug formulations. The base… Read more »
UNDERWRITERS AND PARTNERS